{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:32:30Z","timestamp":1787499150419,"version":"build-2736575974"},"reference-count":13,"publisher":"BMJ","issue":"e1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Eur J Hosp Pharm"],"accepted":{"date-parts":[[2018,9,25]]},"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1136\/ejhpharm-2018-001616","type":"journal-article","created":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T12:15:36Z","timestamp":1540037736000},"page":"e2-e6","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":14,"title":["Therapeutic drug monitoring of levetiracetam in daily clinical practice: high-performance liquid chromatography versus immunoassay"],"prefix":"10.1136","volume":"27","author":[{"given":"Maria","family":"Mendoza Aguilera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Dolores","family":"Bell\u00e9s Medall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"\u00c1lvarez Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d3scar","family":"Pascual Marmaneu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5500-9307","authenticated-orcid":false,"given":"Carla","family":"Li\u00f1ana Granell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ra\u00fal","family":"Ferrando Piqueres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2018,10,20]]},"reference":[{"key":"2024052710253594000_27.e1.e2.1","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.3390\/ph3061909","article-title":"Therapeutic drug monitoring of the newer anti-epilepsy medications","volume":"3","author":"Krasowski","year":"2010","journal-title":"Pharmaceuticals"},{"key":"2024052710253594000_27.e1.e2.2","unstructured":"Keppra Data sheet. http:\/\/www.ema.europa.eu\/docs\/es_ES\/document_library\/ (accessed 15 Jan 2018)."},{"key":"2024052710253594000_27.e1.e2.3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2008.01561.x"},{"key":"2024052710253594000_27.e1.e2.4","unstructured":"Patsalos PN . Antiepileptic Drug Interactions: A Clinical Guide. Guildford: Clarius Press, 2005."},{"key":"2024052710253594000_27.e1.e2.5","doi-asserted-by":"crossref","first-page":"208","DOI":"10.18773\/austprescr.2016.071","article-title":"Paediatric pharmacokinetics and drug doses","volume":"39","author":"O\u2019Hara","year":"2016","journal-title":"Aust Prescr"},{"key":"2024052710253594000_27.e1.e2.6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2007.01032.x"},{"key":"2024052710253594000_27.e1.e2.7","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.farma.2010.10.005","article-title":"Monitorizaci\u00f3n farmacocin\u00e9tica de antiepil\u00e9pticos","volume":"35","author":"Aldaz","year":"2011","journal-title":"Farmacia Hospitalaria"},{"key":"2024052710253594000_27.e1.e2.8","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1515\/cclm-2014-0472","article-title":"Development and validation of a HPLC-UV method for the quantification of antiepileptic drugs in dried plasma spots","volume":"53","author":"Baldelli","year":"2015","journal-title":"Clin Chem Lab Med"},{"key":"2024052710253594000_27.e1.e2.9","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9673(03)00716-7"},{"key":"2024052710253594000_27.e1.e2.10","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.289"},{"key":"2024052710253594000_27.e1.e2.11","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/FTD.0b013e3182048e05","article-title":"Performance characteristics of a new levetiracetam immunoassay and method comparison with a high-performance liquid chromatography method","volume":"33","author":"Reineks","year":"2011","journal-title":"Ther Drug Monit"},{"key":"2024052710253594000_27.e1.e2.12","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/FTD.0000000000000060","article-title":"Therapeutic drug monitoring of levetiracetam: comparison of a novel immunoassay with an HPLC method","volume":"36","author":"Bianchi","year":"2014","journal-title":"Ther Drug Monit"},{"key":"2024052710253594000_27.e1.e2.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2007.11.027"}],"container-title":["European Journal of Hospital Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ejhpharm-2018-001616","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T13:25:47Z","timestamp":1716816347000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejhp.bmj.com\/lookup\/doi\/10.1136\/ejhpharm-2018-001616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,20]]},"references-count":13,"journal-issue":{"issue":"e1","published-online":{"date-parts":[[2020,3,26]]},"published-print":{"date-parts":[[2020,3]]}},"alternative-id":["10.1136\/ejhpharm-2018-001616"],"URL":"https:\/\/doi.org\/10.1136\/ejhpharm-2018-001616","relation":{},"ISSN":["2047-9956","2047-9964"],"issn-type":[{"value":"2047-9956","type":"print"},{"value":"2047-9964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,20]]}}}